Gene therapy specific for ovarian cancer by IAI.3B promoter-driven oncolytic adenovirus

被引：0
|
作者：
Hamada, Katsuyuki [1 ]
机构：
[1] Ehime Univ, Matsuyama, Ehime, Japan
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3006
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Gene therapy for oral squamous cell carcinoma with IAI.3B promoter-driven oncolytic adenovirus-infected carrier cells
    Zhang, Ting
    Hamada, Katsuyuki
    Hyodo, Masamitsu
    Itoh, Hiroshi
    Tani, Kenzaburo
    Goda, Hiroyuki
    Nakashiro, Koh-Ichi
    Hamakawa, Hiroyuki
    ONCOLOGY REPORTS, 2011, 25 (03) : 795 - 802
  • [2] IAI.3B promoter is ovarian cancer specific
    Hamada, K
    MOLECULAR THERAPY, 2004, 9 : S379 - S379
  • [3] Identification of the human IAI.3B promoter element and its use in the construction of a replication-selective adenovirus for ovarian cancer therapy
    Hamada, K
    Kohno, S
    Iwamoto, M
    Yokota, H
    Okada, M
    Tagawa, M
    Hirose, S
    Yamasaki, K
    Shirakata, Y
    Hashimoto, K
    Ito, M
    CANCER RESEARCH, 2003, 63 (10) : 2506 - 2512
  • [4] Ovarian Cancer-Specific Gene Therapy by Oncolytic Adenovirus
    Hamada, Katsuyuki
    MOLECULAR THERAPY, 2006, 13 : S56 - S56
  • [5] A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy
    Leja, Justyna
    Dzojic, Helena
    Gustafson, Elisabet
    Oberg, Kjell
    Giandomenico, Valeria
    Essand, Magnus
    CLINICAL CANCER RESEARCH, 2007, 13 (08) : 2455 - 2462
  • [6] Telomerase promoter-driven cancer gene therapy
    Gu, R
    Fang, BL
    CANCER BIOLOGY & THERAPY, 2003, 2 (04) : S64 - S70
  • [7] TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection
    Yao, Xinglei
    Yoshioka, Yasuo
    Eto, Yusuke
    Morishige, Tomohiro
    Okada, Yuka
    Mizuguchi, Hiroyuki
    Mukal, Yohei
    Okada, Naoki
    Nakagawa, Shinsaku
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 362 (02) : 419 - 424
  • [8] Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter
    Hamada, Katsuyuki
    Shirakawa, Toshiro
    Terao, Shuji
    Gotoh, Akinobu
    Tani, Kenzaburo
    Huang, Wenlin
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2014, 1 : 14019
  • [9] Specific Oncolytic Adenovirus Driven by Human A33 Promoter Region for Colorectal Cancer Therapy
    Cafferata, Eduardo G.
    Maccio, Daniela R.
    Lopez, Maria V.
    Viale, Diego L.
    Podhajcer, Osvaldo L.
    MOLECULAR THERAPY, 2006, 13 : S245 - S245
  • [10] Advancing Lung Cancer Treatment with Combined c-Met Promoter-Driven Oncolytic Adenovirus and Rapamycin
    Chen, Shih-Yao
    Wang, Chung-Teng
    Huang, Tang-Hsiu
    Tsai, Jeng-Liang
    Wang, Hao-Tien
    Yen, Yi-Ting
    Tseng, Yau-Lin
    Wu, Chao-Liang
    Chang, Jia-Ming
    Shiau, Ai-Li
    CELLS, 2024, 13 (18)
12345